The overexpression of ALCAM is also an independent prognosis marker for poor survival and early tumor relapse in PDAC [65], with secreted ALCAM being proposed to be a novel diagnostic marker for pancreatic cancer [66]. Here, ALCAM is linked to pancreatic neoplasm.